My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy.

    Schwaber MJ, Carmeli Y.

    Crit Care. 2009;13(1):106. Epub 2009 Jan 12. Review.PMID: 19216721 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.

    Dudley MN, Ambrose PG.

    Curr Opin Microbiol. 2000 Oct;3(5):515-21. Review.PMID: 11050452 [PubMed - indexed for MEDLINE]Related articles

    3.

    Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

    Li RC, Zhu M, Schentag JJ.

    Clin Pharmacokinet. 1999 Jul;37(1):1-16. Review.PMID: 10451780 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.

    Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD.

    BMC Infect Dis. 2008 Sep 15;8:116.PMID: 18793400 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.

    Figueiredo Costa S.

    Shock. 2008 Oct;30 Suppl 1:23-9. Review.PMID: 18704013 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical implications of antimicrobial resistance for therapy.

    Macgowan AP; BSAC Working Parties on Resistance Surveillance.

    J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii105-14. Review.PMID: 18819975 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antimicrobial resistance: factors and outcomes.

    Fish DN, Ohlinger MJ.

    Crit Care Clin. 2006 Apr;22(2):291-311, vii. Review.PMID: 16678001 [PubMed - indexed for MEDLINE]Related articles

    8.

    Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.

    DeRyke CA, Maglio D, Nicolau DP.

    Expert Opin Pharmacother. 2005 Jun;6(6):873-89. Review.PMID: 15952918 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quality measures of antimicrobial drug use.

    Gyssens IC.

    Int J Antimicrob Agents. 2001 Jan;17(1):9-19. Review.PMID: 11137643 [PubMed - indexed for MEDLINE]Related articles

    10.

    Appropriate vs. inappropriate antimicrobial therapy.

    Davey PG, Marwick C.

    Clin Microbiol Infect. 2008 Apr;14 Suppl 3:15-21. Review.PMID: 18318875 [PubMed - indexed for MEDLINE]Related articles

    11.

    Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges.

    Masterton R, Drusano G, Paterson DL, Park G.

    J Hosp Infect. 2003 Nov;55 Suppl 1:1-12. Review.PMID: 14623198 [PubMed - indexed for MEDLINE]Related articles

    12.

    The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimens.

    Maglio D, Nicolau DP.

    Methods Find Exp Clin Pharmacol. 2004 Dec;26(10):781-8. Review.PMID: 15672121 [PubMed - indexed for MEDLINE]Related articles

    13.

    Importance of adequate initial antimicrobial therapy.

    Ramphal R.

    Chemotherapy. 2005 Jul;51(4):171-6. Epub 2005 Jun 23. Review.PMID: 15980627 [PubMed - indexed for MEDLINE]Related articles

    14.

    Strategies for minimizing antimicrobial resistance.

    Pflomm JM.

    Am J Health Syst Pharm. 2002 Apr 15;59(8 Suppl 3):S12-5.PMID: 11977861 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.

    Antimicrob Agents Chemother. 2005 Feb;49(2):760-6.PMID: 15673761 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model.

    Singer ME, Harding I, Jacobs MR, Jaffe DH.

    J Antimicrob Chemother. 2003 May;51(5):1269-82. Epub 2003 Apr 14.PMID: 12697646 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The case for pathogen-specific therapy.

    Casadevall A.

    Expert Opin Pharmacother. 2009 Aug;10(11):1699-703.PMID: 19558338 [PubMed - indexed for MEDLINE]Related articles

    18.

    When "S" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection.

    Gillespie EL, Kuti JL, Nicolau DP.

    Conn Med. 2005 Apr;69(4):203-10. Review.PMID: 15926635 [PubMed - indexed for MEDLINE]Related articles

    19.

    Containing costs and containing bugs: are they mutually exclusive?

    Nicolau DP.

    J Manag Care Pharm. 2009 Mar;15(2 Suppl):S12-7.PMID: 19236136 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of appropriateness of initial antibiotic therapy on outcome of postoperative pneumonia.

    Fujita T, Ishida Y, Yanaga K.

    Langenbecks Arch Surg. 2008 Jul;393(4):487-91. Epub 2008 Jan 5.PMID: 18176815 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk